Metabolic Panel Testing Market Size and Outlook 2031

Report Description

Key Insights	Details
Forecast Period	2027-2031
Market Size (2025)	USD 12.86 Billion
CAGR (2026-2031)	9.83%
Fastest Growing Segment	Diabetes
Largest Market	North America
Market Size (2031)	USD 22.57 Billion

Market Overview

The Global Metabolic Panel Testing Market is projected to grow from USD 12.86 Billion in 2025 to USD 22.57 Billion by 2031 at a 9.83% CAGR. The Global Metabolic Panel Testing Market encompasses diagnostic blood tests designed to evaluate organ function and screen for various conditions, including diabetes, kidney, and liver diseases, by measuring key metabolites, electrolytes, and enzymes. Market expansion is primarily driven by the increasing global prevalence of chronic diseases, a growing geriatric population requiring regular health monitoring, and a rising emphasis on preventive healthcare initiatives. The escalating demand for routine screenings to facilitate early detection and management of chronic conditions significantly propels market growth.

According to MedTech Europe, an industrial association, total in vitro diagnostic (IVD) market revenues across the EU27, EFTA, and the United Kingdom reached €13.3 billion in 2023, reflecting a decline primarily due to reduced COVID-19 testing volumes compared to previous years. A notable challenge impeding market expansion is the complexity and variability of regulatory compliance and reimbursement policies across diverse geographical regions.

Key Market Drivers

Rising Global Burden of Chronic Diseases
The rising global burden of chronic diseases significantly propels the metabolic panel testing market. Conditions such as diabetes, kidney disease, and liver disease necessitate frequent diagnostic monitoring to manage progression and prevent complications. For example, according to the Institute for Health Metrics and Evaluation, published in November 2025, the number of adults living with chronic kidney disease has reached nearly 800 million worldwide, underscoring the extensive need for metabolic panel tests that evaluate kidney function. This increasing disease prevalence directly translates into a sustained demand for diagnostic solutions that offer early detection and ongoing assessment of metabolic imbalances.

Aging Population and Proactive Health Management
The increasing geriatric population also serves as a crucial driving force for the Global Metabolic Panel Testing Market. Older individuals are more susceptible to developing multiple chronic conditions that require regular health screenings and diagnostic interventions. According to the World Economic Forum, published in October 2025, the global population of people aged 60 and above is expected to increase from 1.1 billion in 2023 to 1.4 billion in 2030, which will further amplify the need for comprehensive metabolic health assessments. This demographic shift, coupled with a greater emphasis on proactive health management for seniors, boosts the utilization of metabolic panels for routine check-ups and disease monitoring. Overall, Quest Diagnostics Incorporated reported first quarter revenues of $2.90 billion in April 2026, reflecting continued demand in the diagnostics sector.

Download Free Sample Report

Key Market Challenges

The complexity and variability of regulatory compliance and reimbursement policies across diverse geographical regions present a substantial impediment to the growth of the Global Metabolic Panel Testing Market. These varying frameworks necessitate distinct development pathways, extensive documentation, and localized clinical validation for manufacturers, directly increasing research and development expenditure and prolonging time to market for new or improved metabolic panel assays. According to Team-NB, the European Association of Medical devices Notified Bodies, in a May 2026 survey covering 2025, the growth of In Vitro Diagnostic Regulation (IVDR) certificates slowed to 45%, a significant decline from previous years when certificates had doubled annually. This slowdown in regulatory approvals directly reflects the challenges in bringing new diagnostic tests to market. Furthermore, more than half of medical device companies in the European Union reduced their product portfolios in 2025 to navigate these regulatory complexities, indicating a direct curtailment of market offerings. Concurrently, fragmented reimbursement landscapes introduce significant unpredictability for manufacturers, hindering strategic planning and market penetration for essential metabolic panel tests.

Key Market Trends

The Global Metabolic Panel Testing Market is significantly influenced by the emergence of remote diagnostics and home sample collection, a trend that decentralizes traditional laboratory testing by enabling individuals to conduct certain metabolic assessments from their homes. This shift is driven by increasing consumer demand for convenience, privacy, and proactive health management, particularly for chronic conditions requiring regular monitoring. Technologies such as continuous glucose monitors exemplify this trend, offering real-time metabolic insights without clinic visits. Abbott Laboratories reported that sales of its continuous glucose monitors in the Diabetes Care segment grew 14.2% on a reported basis in the first quarter of 2026, underscoring the expanding adoption of at-home metabolic testing solutions. This evolution broadens market accessibility and empowers patients with greater control over their health data.

Another pivotal trend is the integration of predictive analytics and artificial intelligence (AI) into metabolic panel testing, enhancing diagnostic capabilities and enabling more personalized healthcare interventions. AI algorithms analyze complex metabolic data from various sources to identify subtle patterns indicative of disease risk, progression, or optimal treatment pathways, moving beyond conventional diagnostic interpretations. This analytical depth supports the development of precision medicine strategies tailored to individual patient profiles. According to AdvaMed, a medical technology industrial association, as of December 2025, the FDA had authorized over 1,300 AI-enabled medical devices, demonstrating the rapid incorporation of advanced analytical tools into diagnostic applications. The synergistic application of AI in metabolic testing is poised to deliver more accurate prognoses and guide more effective therapeutic decisions.

Segmental Insights

The Diabetes segment is a key driver for the Global Metabolic Panel Testing Market, experiencing rapid expansion due to the increasing worldwide prevalence of diabetes and prediabetes. The escalating incidence of lifestyle-related conditions, such as obesity and sedentary habits, significantly contributes to this surge in diabetes cases, necessitating comprehensive metabolic evaluation for diagnosis and ongoing management. Metabolic panel tests are crucial for monitoring vital markers like glucose levels, kidney function, and liver function in diabetic patients, enabling timely intervention and improving patient outcomes. Furthermore, growing awareness initiatives from organizations like the International Diabetes Federation emphasize the urgent need for consistent screening, thereby boosting demand.

Regional Insights

North America stands as the leading region in the Global Comprehensive Metabolic Panel Testing Market due to several reinforcing factors. The region exhibits a high burden of chronic diseases, including diabetes and kidney disorders, which necessitates frequent metabolic screening and ongoing monitoring. This demand is met by a highly developed healthcare infrastructure, extensive insurance coverage, and a strong presence of advanced diagnostic companies. Proactive government initiatives supporting early disease diagnosis, alongside a growing public awareness of preventive health measures, further solidify North America's dominance in adopting and utilizing metabolic panel testing services.

Recent Developments

In May 2026, Metabolic, a healthcare provider specializing in integrated metabolic and chronic disease management, partnered with Roche, a leading in-vitro diagnostics provider. This collaboration introduced Elecsys® pTau217 plasma immunoassay testing as a research screening tool. Metabolic became one of the first globally to offer this test for the early detection of Alzheimer's Disease in patients with metabolic risk factors, such as diabetes and obesity. The initiative leverages advanced diagnostics to address the link between metabolic dysfunction and cognitive health, aiming to improve early detection strategies for high-risk individuals.
In May 2026, Roche launched its Liver Disease Panel, a comprehensive digital portfolio comprising biomarker and digital algorithm solutions. This panel was designed to support the management of chronic liver disease, including conditions like metabolic dysfunction-associated steatotic liver disease (MASLD). Through a collaboration with Evido, the panel incorporates LiverPRO, an algorithm that utilizes existing patient data and routine blood-based biomarkers to assess the risk of liver fibrosis. This innovation aims to reduce the reliance on invasive tests and enable a more proactive approach to managing metabolic liver conditions.
In November 2025, Maven Health commenced the commercial launch of its Metabolic Insights test across the United Kingdom and Ireland. The rollout was executed through its distribution partner, Regenerus Labs. This innovative saliva-based platform is designed to identify metabolic intermediates within key biochemical pathways. The introduction of this non-invasive sampling method aims to provide practitioners with actionable nutritional recommendations and address the growing demand for preventive health services focused on metabolic health.
In June 2025, Labcorp, a global leader in laboratory services, introduced Labcorp Whole Health Solutions. This new offering provided healthcare providers with a specialized menu of over 1,000 biomarkers and seven distinct test panels. These panels were developed to deliver comprehensive insights into cardiometabolic health, hormone balance, micronutrient levels, longevity, and overall body wellness. The launch aimed to meet the evolving needs of functional medicine, integrative medicine, and primary care practitioners by offering convenient and scientifically validated biomarker testing solutions that support holistic patient care.

Key Market Players

Abbott Laboratories
Quest Diagnostics Incorporated
Laboratory Corporation of America Holdings Limited
Sonic Healthcare Limited
Unipath Specialty Laboratory Limited
SYNLAB International GmbH
ARUP Laboratories
Genoptix, Inc.
Nova Medical, Inc.
Mindray Medical International Limited

By Analytes	By Disease	By End Use	By Region
K+ Na+ Cl- CO2 Glucose BUN Creatinine Ca++ Albumin Total protein ALP ALT AST Total bilirubin	Kidney Disease Liver Disease Diabetes Others	Laboratory PoC PoC (Instruments)	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Metabolic Panel Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Metabolic Panel Testing Market, By Analytes:

K+
Na+
Cl-
CO2
Glucose
BUN
Creatinine
Ca++
Albumin
Total protein
ALP
ALT
AST
Total bilirubin

Metabolic Panel Testing Market, By Disease:

Kidney Disease
Liver Disease
Diabetes
Others

Metabolic Panel Testing Market, By End Use:

Laboratory
PoC
PoC (Instruments)

Metabolic Panel Testing Market, By Region:

North America

United States
Canada
Mexico

Europe

France
United Kingdom
Italy
Germany
Spain

Asia Pacific

China
India
Japan
Australia
South Korea

South America

Brazil
Argentina
Colombia

Middle East & Africa

South Africa
Saudi Arabia
UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Metabolic Panel Testing Market.

Available Customizations:

Global Metabolic Panel Testing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Global Metabolic Panel Testing Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1. Product Overview

1.1. Market Definition

1.2. Scope of the Market

1.2.1. Markets Covered

1.2.2. Years Considered for Study

1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study

2.2. Baseline Methodology

2.3. Key Industry Partners

2.4. Major Association and Secondary Sources

2.5. Forecasting Methodology

2.6. Data Triangulation & Validation

2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market

3.2. Overview of Key Market Segmentations

3.3. Overview of Key Market Players

3.4. Overview of Key Regions/Countries

3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Metabolic Panel Testing Market Outlook

5.1. Market Size & Forecast

5.1.1. By Value

5.2. Market Share & Forecast

5.2.1. By Analytes (K+, Na+, Cl-, CO2, Glucose, BUN, Creatinine, Ca++, Albumin, Total protein, ALP, ALT, AST, Total bilirubin)

5.2.2. By Disease (Kidney Disease, Liver Disease, Diabetes, Others)

5.2.3. By End Use (Laboratory, PoC, PoC (Instruments))

5.2.4. By Region

5.2.5. By Company (2025)

5.3. Market Map

6. North America Metabolic Panel Testing Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Analytes

6.2.2. By Disease

6.2.3. By End Use

6.2.4. By Country

6.3. North America: Country Analysis

6.3.1. United States Metabolic Panel Testing Market Outlook

6.3.1.1. Market Size & Forecast

6.3.1.1.1. By Value

6.3.1.2. Market Share & Forecast

6.3.1.2.1. By Analytes

6.3.1.2.2. By Disease

6.3.1.2.3. By End Use

6.3.2. Canada Metabolic Panel Testing Market Outlook

6.3.2.1. Market Size & Forecast

6.3.2.1.1. By Value

6.3.2.2. Market Share & Forecast

6.3.2.2.1. By Analytes

6.3.2.2.2. By Disease

6.3.2.2.3. By End Use

6.3.3. Mexico Metabolic Panel Testing Market Outlook

6.3.3.1. Market Size & Forecast

6.3.3.1.1. By Value

6.3.3.2. Market Share & Forecast

6.3.3.2.1. By Analytes

6.3.3.2.2. By Disease

6.3.3.2.3. By End Use

7. Europe Metabolic Panel Testing Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Analytes

7.2.2. By Disease

7.2.3. By End Use

7.2.4. By Country

7.3. Europe: Country Analysis

7.3.1. Germany Metabolic Panel Testing Market Outlook

7.3.1.1. Market Size & Forecast

7.3.1.1.1. By Value

7.3.1.2. Market Share & Forecast

7.3.1.2.1. By Analytes

7.3.1.2.2. By Disease

7.3.1.2.3. By End Use

7.3.2. France Metabolic Panel Testing Market Outlook

7.3.2.1. Market Size & Forecast

7.3.2.1.1. By Value

7.3.2.2. Market Share & Forecast

7.3.2.2.1. By Analytes

7.3.2.2.2. By Disease

7.3.2.2.3. By End Use

7.3.3. United Kingdom Metabolic Panel Testing Market Outlook

7.3.3.1. Market Size & Forecast

7.3.3.1.1. By Value

7.3.3.2. Market Share & Forecast

7.3.3.2.1. By Analytes

7.3.3.2.2. By Disease

7.3.3.2.3. By End Use

7.3.4. Italy Metabolic Panel Testing Market Outlook

7.3.4.1. Market Size & Forecast

7.3.4.1.1. By Value

7.3.4.2. Market Share & Forecast

7.3.4.2.1. By Analytes

7.3.4.2.2. By Disease

7.3.4.2.3. By End Use

7.3.5. Spain Metabolic Panel Testing Market Outlook

7.3.5.1. Market Size & Forecast

7.3.5.1.1. By Value

7.3.5.2. Market Share & Forecast

7.3.5.2.1. By Analytes

7.3.5.2.2. By Disease

7.3.5.2.3. By End Use

8. Asia Pacific Metabolic Panel Testing Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Analytes

8.2.2. By Disease

8.2.3. By End Use

8.2.4. By Country

8.3. Asia Pacific: Country Analysis

8.3.1. China Metabolic Panel Testing Market Outlook

8.3.1.1. Market Size & Forecast

8.3.1.1.1. By Value

8.3.1.2. Market Share & Forecast

8.3.1.2.1. By Analytes

8.3.1.2.2. By Disease

8.3.1.2.3. By End Use

8.3.2. India Metabolic Panel Testing Market Outlook

8.3.2.1. Market Size & Forecast

8.3.2.1.1. By Value

8.3.2.2. Market Share & Forecast

8.3.2.2.1. By Analytes

8.3.2.2.2. By Disease

8.3.2.2.3. By End Use

8.3.3. Japan Metabolic Panel Testing Market Outlook

8.3.3.1. Market Size & Forecast

8.3.3.1.1. By Value

8.3.3.2. Market Share & Forecast

8.3.3.2.1. By Analytes

8.3.3.2.2. By Disease

8.3.3.2.3. By End Use

8.3.4. South Korea Metabolic Panel Testing Market Outlook

8.3.4.1. Market Size & Forecast

8.3.4.1.1. By Value

8.3.4.2. Market Share & Forecast

8.3.4.2.1. By Analytes

8.3.4.2.2. By Disease

8.3.4.2.3. By End Use

8.3.5. Australia Metabolic Panel Testing Market Outlook

8.3.5.1. Market Size & Forecast

8.3.5.1.1. By Value

8.3.5.2. Market Share & Forecast

8.3.5.2.1. By Analytes

8.3.5.2.2. By Disease

8.3.5.2.3. By End Use

9. Middle East & Africa Metabolic Panel Testing Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.2.1. By Analytes

9.2.2. By Disease

9.2.3. By End Use

9.2.4. By Country

9.3. Middle East & Africa: Country Analysis

9.3.1. Saudi Arabia Metabolic Panel Testing Market Outlook

9.3.1.1. Market Size & Forecast

9.3.1.1.1. By Value

9.3.1.2. Market Share & Forecast

9.3.1.2.1. By Analytes

9.3.1.2.2. By Disease

9.3.1.2.3. By End Use

9.3.2. UAE Metabolic Panel Testing Market Outlook

9.3.2.1. Market Size & Forecast

9.3.2.1.1. By Value

9.3.2.2. Market Share & Forecast

9.3.2.2.1. By Analytes

9.3.2.2.2. By Disease

9.3.2.2.3. By End Use

9.3.3. South Africa Metabolic Panel Testing Market Outlook

9.3.3.1. Market Size & Forecast

9.3.3.1.1. By Value

9.3.3.2. Market Share & Forecast

9.3.3.2.1. By Analytes

9.3.3.2.2. By Disease

9.3.3.2.3. By End Use

10. South America Metabolic Panel Testing Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value

10.2. Market Share & Forecast

10.2.1. By Analytes

10.2.2. By Disease

10.2.3. By End Use

10.2.4. By Country

10.3. South America: Country Analysis

10.3.1. Brazil Metabolic Panel Testing Market Outlook

10.3.1.1. Market Size & Forecast

10.3.1.1.1. By Value

10.3.1.2. Market Share & Forecast

10.3.1.2.1. By Analytes

10.3.1.2.2. By Disease

10.3.1.2.3. By End Use

10.3.2. Colombia Metabolic Panel Testing Market Outlook

10.3.2.1. Market Size & Forecast

10.3.2.1.1. By Value

10.3.2.2. Market Share & Forecast

10.3.2.2.1. By Analytes

10.3.2.2.2. By Disease

10.3.2.2.3. By End Use

10.3.3. Argentina Metabolic Panel Testing Market Outlook

10.3.3.1. Market Size & Forecast

10.3.3.1.1. By Value

10.3.3.2. Market Share & Forecast

10.3.3.2.1. By Analytes

10.3.3.2.2. By Disease

10.3.3.2.3. By End Use

11. Market Dynamics

11.1. Drivers

11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)

12.2. Product Launches (If Any)

12.3. Recent Developments

13. Global Metabolic Panel Testing Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry

14.2. Potential of New Entrants

14.3. Power of Suppliers

14.4. Power of Customers

14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Abbott Laboratories

15.1.1. Business Overview

15.1.2. Products & Services

15.1.3. Recent Developments

15.1.4. Key Personnel

15.1.5. SWOT Analysis

15.2. Quest Diagnostics Incorporated

15.3. Laboratory Corporation of America Holdings Limited

15.4. Sonic Healthcare Limited

15.5. Unipath Specialty Laboratory Limited

15.6. SYNLAB International GmbH

15.7. ARUP Laboratories

15.8. Genoptix, Inc.

15.9. Nova Medical, Inc.

15.10. Mindray Medical International Limited

16. Strategic Recommendations

17. About Us & Disclaimer

Report Description

Table of content

Figures and Tables

Frequently asked questions

What was the market size of the Global Metabolic Panel Testing Market in 2025?

Which is the dominating region in the Global Metabolic Panel Testing Market?

Which is the fastest growing segment in the Global Metabolic Panel Testing Market?

What is the expected growth rate of the Global Metabolic Panel Testing Market?